Medicamen Biotech Ltd. reported that Geetika Madan, an immediate relative of CEO Rajesh Madan, sold 2,490 equity shares on the market for ₹11,07,235.51, reducing her holdings to 30,000 shares (0.23%). This is a compliance notice under SEBI regulations regarding insider trading.